Label-Free Quantification of Anti-TNF-α in Patients Treated with Adalimumab Using an Optical Biosensor

This study describes the development of an immunosensory label-free quantification methodology based on surface plasmon resonance (SPR) and its applicability in measuring/evaluating therapeutic drug monitoring (TDM) of anti-TNF-α monoclonal antibody (adalimumab) in rheumatoid arthritis (RA) patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Bustos, Rosa Helena, Zapata, Carlos, Esteban, Efraín, García, Julio-César, Jáuregui, Edwin, Jaimes, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876701/
https://www.ncbi.nlm.nih.gov/pubmed/29495408
http://dx.doi.org/10.3390/s18030691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876701/
https://www.ncbi.nlm.nih.gov/pubmed/29495408
http://dx.doi.org/10.3390/s18030691

Ejemplares similares